Amgen (AMGN) Tops Q3 EPS by 23c

Amgen (NASDAQ: AMGN) reported Q3 EPS of $3.34, $0.23 better than the analyst estimate of $3.11. Revenue for the quarter came in at $5.77 billion versus the consensus estimate of $5.76 billion.

GUIDANCE:

Amgen sees FY2017 EPS of $12.50-$12.70, versus the consensus of $12.57. Amgen sees FY2017 revenue of $22.7-23 billion, versus the consensus of $22.87 billion.

For earnings history and earnings-related data on Amgen (AMGN) click here.

You May Also Be Interested In

• Jabil (JBL) Tops Q3 EPS by 8c, Offers Guidance
• Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight
• Goldman Sachs Starts Chagee Holdings (CHA) at Neutral